Pfizer: FY02 net rises 20% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer: FY02 net rises 20%

Jan 29, 2002

Pfizer has declared a net profit growth of 20% for the year ended November'01 as against 11% growth in sales. There is has been a marginal rise in operating margins of the company to 7.2% from 6.3% last year. Equity captial has gone up due to bonus issue last year.

(Rs m)FY01FY02% Change
Sales 2,878 3,206 11.4%
Other Income 516 61519.1%
Expenditure 2,696 2,977 10.4%
Operating Profit (EBDIT) 182 230 26.1%
Operating Profit Margin (%)6.3%7.2%13.1%
Interest 43-29.7%
Depreciation68725.9%
Profit before Tax 627 770 22.8%
Tax232.5295.327.0%
Profit after Tax/(Loss) 395 475 20.3%
Net profit margin (%)13.7%14.8%
No. of Shares (eoy) (m)11.723.4
Diluted Earnings per share*33.720.3
P/E (at current price) 21.1
(*- annualised)

Other Income includes service income of Rs 483 m a rise of 14% over previous year. The marginal rise in margins seems to be on the back of new products, especially Magnex and Hepashield. However, even in new product launches the company is facing stiff price competition. The rise in margins has also been helped by presence of VRS cost in last year to the tune of Rs 23.9 m.

At the current market price of Rs 458, the stock is trading at a P/e of 21x FY02 earnings. The company has declared 50% dividend for the year.

Equitymaster requests your view! Post a comment on "Pfizer: FY02 net rises 20%". Click here!

  

More Views on News

PFIZER 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PFIZER for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 26, 2021 (Close)

TRACK PFIZER

PFIZER - MYLAN COMPARISON

COMPARE PFIZER WITH

MARKET STATS